";s:4:"text";s:4960:" %����
<<77E4D97E9DC2374391BF0467F553BFE7>]>>
0
startxref
0000021882 00000 n
0000006762 00000 n
0000002547 00000 n
%PDF-1.6
%����
1 0 obj
pharmacokinetic and pharmacodynamic principles governing the interactions of warfarin with specific drugs listed in the main section of the handout. ... Interactions Drug-Drug: Abciximab,androgens capecitabine cefotetan chloram-phenicol,clopidogrel,disulfiram,fluconazole,fluoroquinolones,itracona- ... Do not confuse Coumadin (warfarin) with Avandia (rosiglitazone) or The following foods should be avoided or limited, since they also can effect warfarin therapy: caffeinated beverages (cola, coffee, tea, hot chocolate, chocolate milk). CAPITALS indicate life-threatening, underlines indicate most frequent. (7) • Inhibitors and inducers of CYP2C9, 1A2, or 3A4: May alter warfarin exposure. <>>>
{8�]>���ޤ���-n�{nJmPs��a��
Z�D9��9��U�P��;����g]fz�*a�G6��&�>W��!�O[����{��N(8�PHG�cH��jU���Wk�j���-2[*0���4�@~(;�^gN����4H��V.�u�? endstream
endobj
2395 0 obj
<>/Size 2361/Type/XRef>>stream
0000021435 00000 n
0000015894 00000 n
Inpatient Guideline for Management of Significant Warfarin Drug-Drug Interactions with Antimicrobial Agents Purpose: The purpose of this guideline is to provide assistance with dose adjustment of warfarin when initiating antimicrobial therapy that may affect the INR Recommendations are intended for patients with expected antimicrobial interaction duration ≥3 days 0000005100 00000 n
xڬT{HSQ>����ٖ�Y�+�Nc7z궢wPb�S��FV6�\I2kF.k��٢A#�^h�;�J�I��$
������9wN�;p��^���� @ [ � �m�`dE@Ty�����0����ͽ��~x��k2� 0000008954 00000 n
0000010141 00000 n
��c�JȐ�ݿ_�p����`�8���ڠ�[FzK�9���-l�M�!�����wΥ#����,����+� ��7�ZW������5��;X��[�>H����c0.[^�v1�P+8J�`6�O"�Q�>m�ݧ=x��ho8yU�Z�n^U0�4��>m��cE�A��R���t�CK���A��OV�\@��^��y�5�!xh�u}O��ԛ�c��A@pl�ʊ� 0000018740 00000 n
Be able to use cytochrome P450 interaction tables to identify the interactions of other drugs with both R- and S-warfarin. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 792 612] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
r�d��o��6�!ڧ�
֍M�:D�f�|+U"'�A6"gC� #F��GY��ˈ� )u,zd`�w�e��(�h:a�_�֯�$�gj9��V�:+̠�������7���6И�)��=��V6�>�)���ׂ6�9G;>�(���9.���_b���|^>�T)��6�����(����y cy������&ne�f�dr +C���������? about interactions with COUMADIN or increased risks for bleeding. ���&�@�oND�VV��[���a*#}|���W��0���k&\N���ٰrk -N 5b�g�%�� �Χ�m���SWwk���6��M����1�A�:�K�N�Ǻ